Skip to content

Synbiotic trial found less visceral fat, without clear broader metabolic changes

The scan result favored a specific formulation, while BMI, waist circumference and blood measures showed no significant changes.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

The synbiotic reduced scan-measured visceral fat area compared with placebo, but the abstract does not say how large the difference was. Blood biochemistry, BMI and waist circumference showed no statistically significant changes. The findings concern this particular combined formulation and do not establish a broader metabolic benefit or apply to all probiotic products.

Keep in mind

The abstract omits the size of the visceral-fat difference and its confidence interval, so practical importance remains unclear. It also does not describe safety outcomes.

THE NUMBERS, WITH CONTEXT

What researchers found

p = 0.048

Statistical evidence for visceral fat area change

Synbiotic versus placebo, baseline to week 12, measured by DXA. The p-value describes statistical evidence, not the amount of fat lost. The effect size and confidence interval were not reported.

Clin Nutr, 2026 · Original source ↓

What was actually tested

The product combined probiotic strains, prebiotic ingredients and a chrysanthemum extract. Because these were administered together, the trial cannot identify which ingredient, or combination of ingredients, accounted for the reported visceral-fat result.

Other changes complicate interpretation

The subgroup with lower BMI also had increased fat beneath the skin. Increases in certain gut bacteria were temporary. The reported sex comparison was uncertain, so the abstract does not establish a greater benefit for men.

CHECK THE ORIGINAL

The original publication

Effects of a novel synbiotic intervention on abdominal visceral fat reductions and gut microbiota in overweight and obese adults: A randomized, double-blind, placebo-controlled trial.

Li N, Zhu Z, Wu S et al.
Clin Nutr · 2026

PubMed ID
41512635
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.